These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10906412)

  • 1. New highly potent dipeptidic growth hormone secretagogues with low molecular weight.
    Peschke B; Ankersen M; Hansen TK; Hansen BS; Lau J; Nielsen KK; Raun K
    Eur J Med Chem; 2000 Jun; 35(6):599-618. PubMed ID: 10906412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterisation of a new oral GH secretagogue, NN703.
    Hansen BS; Raun K; Nielsen KK; Johansen PB; Hansen TK; Peschke B; Lau J; Andersen PH; Ankersen M
    Eur J Endocrinol; 1999 Aug; 141(2):180-9. PubMed ID: 10427162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.
    Hansen TK; Ankersen M; Raun K; Hansen BS
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1915-8. PubMed ID: 11459660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone secretagogues derived from NN703 with hydrazidesas c-terminal.
    Ankersen M; Kramer Nielsen K; Kruse Hansen T; Raun K; Sehested Hansen B
    Eur J Med Chem; 2000 May; 35(5):487-97. PubMed ID: 10889328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel orally active growth hormone secretagogues.
    Hansen TK; Ankersen M; Hansen BS; Raun K; Nielsen KK; Lau J; Peschke B; Lundt BF; Thøgersen H; Johansen NL; Madsen K; Andersen PH
    J Med Chem; 1998 Sep; 41(19):3705-14. PubMed ID: 9733496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.
    Peschke B; Ankersen M; Bauer M; Hansen TK; Hansen BS; Nielsen KK; Raun K; Richter L; Westergaard L
    Eur J Med Chem; 2002 Jun; 37(6):487-501. PubMed ID: 12204475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues.
    Barakat KJ; Cheng K; Chan WW; Butler BS; Jacks TM; Schleim KD; Hora DF; Hickey GJ; Smith RG; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1431-6. PubMed ID: 9871779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin.
    Carpino PA; Lefker BA; Toler SM; Pan LC; Hadcock JR; Cook ER; DiBrino JN; Campeta AM; DeNinno SL; Chidsey-Frink KL; Hada WA; Inthavongsay J; Mangano FM; Mullins MA; Nickerson DF; Ng O; Pirie CM; Ragan JA; Rose CR; Tess DA; Wright AS; Yu L; Zawistoski MP; DaSilva-Jardine PA; Wilson TC; Thompson DD
    Bioorg Med Chem; 2003 Feb; 11(4):581-90. PubMed ID: 12538023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.
    Ankersen M; Johansen NL; Madsen K; Hansen BS; Raun K; Nielsen KK; Thogersen H; Hansen TK; Peschke B; Lau J; Lundt BF; Andersen PH
    J Med Chem; 1998 Sep; 41(19):3699-704. PubMed ID: 9733495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripeptide growth hormone secretagogues.
    Yang L; Morriello G; Pan Y; Nargund RP; Barakat K; Prendergast K; Cheng K; Chan WW; Smith RG; Patchett AA
    Bioorg Med Chem Lett; 1998 Apr; 8(7):759-64. PubMed ID: 9871537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3657-9. PubMed ID: 17482461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted bridged phenyl piperidines: orally active growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2003 May; 13(10):1817-20. PubMed ID: 12729672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New growth hormone secretagogues: C-terminal modified sulfonamide-analogues of NN703.
    Peschke B; Hansen BS
    Bioorg Med Chem Lett; 1999 May; 9(9):1295-8. PubMed ID: 10340617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent, orally bioavailable benzazepinone growth hormone secretagogue.
    DeVita RJ; Bochis R; Frontier AJ; Kotliar A; Fisher MH; Schoen WR; Wyvratt MJ; Cheng K; Chan WW; Butler B; Jacks TM; Hickey GJ; Schleim KD; Leung K; Chen Z; Chiu SL; Feeney WP; Cunningham PK; Smith RG
    J Med Chem; 1998 May; 41(10):1716-28. PubMed ID: 9572898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure activity studies of the serine-AIB dipeptide domain in 2,3-dihydroisothiazole based growth hormone secretagogues.
    Evers B; Ruehter G; Berg M; Dodge JA; Hankotius D; Hary U; Jungheim LN; Mest HJ; de la Nava EM; Mohr M; Muehl BS; Petersen S; Sommer B; Riedel-Herold G; Tebbe MJ; Thrasher KJ; Voelkers S
    Bioorg Med Chem; 2005 Dec; 13(24):6748-62. PubMed ID: 16219466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242).
    Shaffer CL; Patel NC; Schwarz J; Scialis RJ; Wei Y; Hou XJ; Xie L; Karki K; Bryce DK; Osgood SM; Hoffmann WE; Lazzaro JT; Chang C; McGinnis DF; Lotarski SM; Liu J; Obach RS; Weber ML; Chen L; Zasadny KR; Seymour PA; Schmidt CJ; Hajós M; Hurst RS; Pandit J; O'Donnell CJ
    J Med Chem; 2015 May; 58(10):4291-308. PubMed ID: 25905800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of growth hormone of different molecular weights in rat, dog and human pituitaries.
    Frohman LA; Burek L; Stachura MA
    Endocrinology; 1972 Jul; 91(1):262-9. PubMed ID: 4623634
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
    Hernández AS; Swartz SG; Slusarchyk D; Yan M; Seethala RK; Sleph P; Grover G; Dickinson K; Giupponi L; Harper TW; Humphreys WG; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2067-72. PubMed ID: 18282707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety and Efficacy of Growth Hormone Secretagogues.
    Sigalos JT; Pastuszak AW
    Sex Med Rev; 2018 Jan; 6(1):45-53. PubMed ID: 28400207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent 3-spiropiperidine growth hormone secretagogues.
    Yang L; Morriello G; Prendergast K; Cheng K; Jacks T; Chan WW; Schleim KD; Smith RG; Patchett AA
    Bioorg Med Chem Lett; 1998 Jan; 8(1):107-12. PubMed ID: 9925440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.